1. P041 Characterization of cytokine and drug concentrations in serum, mucosa and faeces during induction treatment of moderate-to-severe ulcerative colitis with anti-TNF monoclonal antibodies. (21st January 2022) Authors: Van Oostrom, J; Hanzel, J; Verstockt, B; Singh, S; Smith, J; Stylli, J; Vermeire, S; D'Haens, G Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P401 Tofacitinib tissue exposure correlates with endoscopic outcome. (21st January 2022) Authors: Verstockt, B; Alsoud, D; van Oostrom, J; Smith, J; Stylli, J; Singh, S; van Gennep, S; Rahimian, P; Sabino, J; Ferrante, M; Singh, S; D'Haens, G; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗